Nxera Pharma Co., Ltd.

DB:JSS Stock Report

Market Cap: €631.2m

Nxera Pharma Future Growth

Future criteria checks 4/6

Nxera Pharma is forecast to grow earnings and revenue by 47.3% and 9.3% per annum respectively. EPS is expected to grow by 52.2% per annum. Return on equity is forecast to be 6.1% in 3 years.

Key information

47.3%

Earnings growth rate

52.2%

EPS growth rate

Pharmaceuticals earnings growth21.6%
Revenue growth rate9.3%
Future return on equity6.1%
Analyst coverage

Good

Last updated15 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:JSS - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202643,2892,2854,6525,1309
12/31/202539,6323,4725,0794,58310
12/31/202434,6761,0312,8093,0508
9/30/202429,275-3,7111,7052,425N/A
6/30/202423,340-9,836-1,526-782N/A
3/31/202416,434-9,072-7,091-6,321N/A
12/31/202312,766-7,193-6,124-5,273N/A
9/30/202312,402-3,37838653N/A
6/30/202315,2581,8609,82110,153N/A
3/31/202315,3931,05010,04310,386N/A
12/31/202215,5693829,6499,952N/A
9/30/202222,763-38314,53414,836N/A
6/30/202217,046-2245,0745,389N/A
3/31/202217,6241006,1656,394N/A
12/31/202117,7121,0176,8947,095N/A
9/30/20217,9891,296-589-448N/A
6/30/20219,4491,2992,0132,140N/A
3/31/20218,8871,0722,1862,313N/A
12/31/20208,8421,4794,5674,672N/A
9/30/20206,399-1,6711,3521,441N/A
6/30/20207,186-1,0804,3154,422N/A
3/31/20207,752-3324,3624,551N/A
12/31/20199,7261,4323,1613,441N/A
12/31/20183,550-6,918-8,648-6,047N/A
9/30/20183,444-5,483-7,726-5,640N/A
6/30/20185,005-4,202N/A-3,358N/A
3/31/20186,955-2,654N/A-2,167N/A
12/31/20178,060-2,608N/A609N/A
9/30/20178,376-1,338N/A211N/A
6/30/20176,603-1,547N/A-1,102N/A
3/31/201718,9019,311N/A12,856N/A
12/31/201617,5286,481N/A11,424N/A
9/30/201621,4509,514N/A15,378N/A
6/30/201622,65810,508N/A17,064N/A
3/31/20168,151-1,432N/A4,471N/A
12/31/201510,4612,599N/A4,928N/A
9/30/20155,646-255N/A1,503N/A
6/30/20154,010-118N/A929N/A
3/31/20153,671568N/A92N/A
12/31/20141,1692,191N/AN/AN/A
9/30/20141,0511,593N/A1,079N/A
6/30/20142,2362,030N/AN/AN/A
3/31/20142,0691,526N/A363N/A
12/31/20131,948-849N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: JSS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: JSS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: JSS is expected to become profitable in the next 3 years.

Revenue vs Market: JSS's revenue (9.3% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: JSS's revenue (9.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: JSS's Return on Equity is forecast to be low in 3 years time (6.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y